Taronis Technologies Inc (fka TRNX)

[Raffis]

TO THE MMMOOONNN. HERE’S WHY:

(THE PHARMACEUTICALS IN THE WATER) - - “... through Taronis Technologies’ extensive research and development activities the company determined it can completely eliminate pharmaceutical contaminants such as antibiotics, hormones and other soluble drugs suspended in contaminated water. In furtherance of this the company is working with one of the largest hospital groups in Spain to implement a hospital-by-hospital approach to medical waste water sterilization. Lastly, Taronis Technologies also owns a controlling interest in Water Pilot, LLC. The WATER PILOT® System immediately reduces water consumption and provides its users with live remote consumption monitoring for long term leak protection and water asset management. An integral, client-based alarm and notification system that reports to any mobile device.

AND,

“Taronis Technologies does not expect to have any material liabilities upon completion of the Spin-Off.”

AND,

What will be the continuing business, operations and material assets and liabilities of Taronis Technologies after the Spin-Off?

A: Taronis Technologies will continue to operate as a technology business focused on implementing and commercializing various water related technologies. Taronis Technologies will do this by focusing on its current three commercially viable operations. First, over the course of Taronis Technologies’ history, the company has successfully obtained and executed on two United States Department of Agriculture (“USDA”) grants which enabled Taronis Technologies to determine that use of the Venturi® units for sterilization of agricultural waste water (both in the hog industry and dairy farm industry) is commercially viable. In furtherance of this, Taronis Technologies is in the process of formalizing a joint venture with a large international hog producer, whereby the Taronis Technologies will assist with the sterilization of hog waste. Second, through Taronis Technologies’ extensive research and development activities the company determined it can completely eliminate pharmaceutical contaminants such as antibiotics, hormones and other soluble drugs suspended in contaminated water. In furtherance of this the company is working with one of the largest hospital groups in Spain to implement a hospital-by-hospital approach to medical waste water sterilization. Lastly, Taronis Technologies also owns a controlling interest in Water Pilot, LLC. The WATER PILOT® System immediately reduces water consumption and provides its users with live remote consumption monitoring for long term leak protection and water asset management. An integral, client-based alarm and notification system that reports to any mobile device. Water Pilot may be appropriate for a wide range of businesses or properties with a water meter. The Water Pilot has seen rapid commercialization in the last several months and Taronis Technologies believes it will be a meaningful source of revenue during 2020 and beyond. In addition to its business operations Taronis Technologies will continue to own assets, including, but not limited to, all of its intellectual property related to the use of the Venturi® units for the sterilization of water, generally, as well as those Venturi® units which have been designed specifically for water sterilization and the company’s interest in the Water Pilot patent portfolio. Other than an existing convertible debenture with a current balance of approximately $0.5 million, Taronis Technologies does not expect to have any material liabilities upon completion of the Spin-Off.

https://www.sec.gov/Archives/edgar/data/1778805/000149315219019153/ex99-1.htm